Semaglutide drugs such as Ozempic and Wegovy have been in Diabetes Control and weight loss.
Research reveals other benefits beyond these main uses – but there are also some negative effects.
Although gastrointestinal problems are the most common side effect, new research from the University of British Columbia links GLP-1 (glucagon-like peptide-1) agonists, including drug categories, to increase the risk of hair loss.
Bald man turns to “new Botox” for hair loss treatment
The researchers analyzed data from 16 million patients from the health claims database, narrowing it down to 1,926 Semaglutide users and 1,348 Bupropion-Nnletrexone users, another type of Weight loss medication.
A recent study by the University of British Columbia has compared the drug category of GLP-1 (glucagon-like peptide 1) agonists, including Ceguaruli, with an increased risk of hair loss. (iStock)
After adjusting for other factors, they found that Semaglutide users were 50% more likely to lose their hair compared to the other group.
Women are more likely to have this result, twice as likely as men.
“Not surprising”
According to Dr. Mahyar Etminan, Epilytics and CEO and CEO of Vancouver, British Columbia, Canada, the researchers were not surprised by the results.
“have [previous] anecdote Reports of hair loss Reports of hair loss in drug clinical trials were also reported. ” he told Fox News Digital.
Hair loss? Intestinal health issues? Dr. Nicole Saphier reveals smart fixes
The findings are not surprising, agrees, Dr. Patrick Davis, a plastic surgeon and hair repair expert in Beverly Hills.
“We have heard this when the patient consulted us about the surgical recovery of the face in later surgery. Fast weight loss“He said in an interview with Fox News Digital.
After adjusting for other factors, the researchers found that Semaglutide users were 50% more likely to lose their hair compared to another group. (iStock)
“Hair growth (and loss) is entirely dependent on factors like diet, essential vitamins, body stress and genetics.”
He noted that during weight loss, the first three factors will play a role—and the loss of semaglutide-driven may be no exception.”
Previous research shows that changes cause stress or affect a person Nutritional intake The doctors add that the risk of hair loss may increase.
“Hair growth (and loss) is entirely dependent on factors like diet, essential vitamins, body stress and genetics.”
“This study refers to those who weigh more than 20% have higher rates of hair loss than those without,” Davis noted.
“This research theory suggests that this may be due to doubt Physiological stressthis may be a symptom of weight loss so quickly. ”
Long-term hair loss seems less likely, doctors say, because “inflammatory events” (weight loss and stress) usually normalize as individuals reach their target weight.
Potential limitations
Researcher Etminan pointed out that the study does have some limitations.
These facts include that it cannot verify hair loss through medical records, but only determines the medical code for hair loss.
Women are more likely to suffer from hemiglutinin-related hair loss, and men are twice as likely to be at risk. (iStock)
Plastic surgeon Davis also noted that the study cites another study in which Wegovy users had a higher risk of hair loss relative to the placebo group (1.4%).
“Although this clearly shows an increased risk, the incidence rate of 3.3% is still very low,” he said.
this Early researchNot published in the preprint server MedRxiv in peer review.
“Future studies are needed to determine the association between semi-spermide and hair loss,” the researchers wrote.
Doctor’s advice
Those who suffer from hair loss while taking semaglutide medication should consult With a dermatologist Etminan recommends that it be determined whether this is due to the adverse effects of these drugs.
“This is a relatively new adverse event and little is known about it,” he said. “The biggest question about who is at risk and whether hair loss will reverse when the drug is stopped in future studies.”
When Fox News Digital contacted Novo Nordisk, the manufacturer of Ozempic and Wegovy, he confirmed that hair loss was a identified risk for Semaglutide and was listed as a side effect in product information. (Gate image)
Davis agrees to encourage patients to have open conversations And their doctor About how they best take care of themselves.
“I believe patients should consider any potential side effects before taking any medications,” he said.
Click here to get the Fox News app
“While the incidence of hair loss remains low, this is a potential trade-off that patients should consider.”
Davis also advises his patients to adopt fiber, protein and Nutritious food To ensure proper nutrition is carried out while taking half a rupees medication.
One expert advises that those who suffer from hair loss while taking semaglutide drugs should consult a dermatologist to determine if this is due to the adverse effects of these drugs. (iStock)
“This not only helps with hair loss, but more importantly, a strong diet can curb unnecessary losses of muscle mass that often occur,” he said. “A proper diet, a conservative weight loss schedule, and Exercise plan Taking this medication is essential. ”
Click here to sign up for our health newsletter
When Fox News Digital contacted Novo Nordisk, the manufacturer of Ozempic and Wegovy, he confirmed that hair loss was a identified risk for Semaglutide and was listed as a side effect in product information.
A spokesperson for the company said: “In Wegovy’s clinical trial, 2.5% of adult patients treated with Wegovy reported hair loss, while in adult patients treated with placebo, hair loss was reported.”
“While the incidence of hair loss remains low, this is a potential trade-off that patients should consider.”
“The frequency of hair loss is higher in patients with greater weight loss (≥20%), suggesting that hair loss events may be related to the magnitude of weight loss.”
“The safety of patients is crucial,” the statement continued. “We are constantly monitoring the safety of our products and working closely with the authorities to ensure that Patient safetyincluding sufficient information about hair loss. ”
For more health articles, please visit www.foxnews.com/health
The study was funded by an internal research fund from the Department of Ophthalmology and Visual Sciences at the University of British Columbia.
